CORMORANT ASSET MANAGEMENT, LP – Celldex Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$0
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -200K shares | -5.39M | $28.11 | 0 |
| Q2 2022 | share | Increase | 0.00% | 200K shares | 5.39M | $26.96 | 200K |
| Q1 2022 | share | Decrease | -100.00% | -100K shares | -3.86M | $34.06 | 0 |
| Q4 2021 | share | Increase | 0.00% | 100K shares | 3.86M | $38.9 | 100K |